Navis GJ - Search Results

1

The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.

de Zeeuw D, Navis GJ, Donker AJ, de Jong PE. de Zeeuw D, et al. Among authors: navis gj. J Hypertens Suppl. 1983 Oct;1(1):93-7. J Hypertens Suppl. 1983. PMID: 6100614 Clinical Trial.

2

Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients.

Navis G, de Jong P, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. J Cardiovasc Pharmacol. 1987 Jun;9(6):743-8. doi: 10.1097/00005344-198706000-00016. J Cardiovasc Pharmacol. 1987. PMID: 2442543 Clinical Trial.

3

Renal effects of ketanserin in essential hypertension.

Navis G, de Jong PE, van der Hem GK, de Zeeuw D. Navis G, et al. J Hypertens Suppl. 1986 Apr;4(1):S95-8. J Hypertens Suppl. 1986. PMID: 2939222

4

Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.

Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. J Clin Hypertens. 1985 Sep;1(3):228-38. J Clin Hypertens. 1985. PMID: 3012004

5

Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.

Navis GJ, de Zeeuw D, de Jong PE. Navis GJ, et al. J Cardiovasc Pharmacol. 1986;8 Suppl 1:S30-4. J Cardiovasc Pharmacol. 1986. PMID: 2422491

6

Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition.

Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. Kidney Int. 1987 Mar;31(3):815-9. doi: 10.1038/ki.1987.71. Kidney Int. 1987. PMID: 3033389 Free article. Clinical Trial.

7

Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?

van Paassen P, de Zeeuw D, Navis G, de Jong PE. van Paassen P, et al. Hypertension. 1996 Feb;27(2):202-8. doi: 10.1161/01.hyp.27.2.202. Hypertension. 1996. PMID: 8567042 Clinical Trial.

8

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.

Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D. Wapstra FH, et al. Clin Sci (Lond). 1996 May;90(5):393-401. doi: 10.1042/cs0900393. Clin Sci (Lond). 1996. PMID: 8665777

9

Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.

Buter H, Navis G, de Zeeuw D, de Jong PE. Buter H, et al. Kidney Int Suppl. 1997 Dec;63:S185-7. Kidney Int Suppl. 1997. PMID: 9407454 Clinical Trial.

10

Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.

de Boer E, Navis G, Wapstra FH, de Jong PE, de Zeeuw D. de Boer E, et al. Kidney Int Suppl. 1999 Jul;71:S42-6. Kidney Int Suppl. 1999. PMID: 10412735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

763 results

Search Page

Filters